Go to industries

Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
Worldwide
426
deals closed in Healthcare
Worldwide
Explore all our industry-related deals
Go to deals
MediCA group has been acquired by Repharm
Healthcare

MediCA group has been acquired by Repharm

CGP Management has sold MediCA group, the largest private provider of healthcare services in Lithuania, to Repharm.

Learn more
BlijWerkt has been acquired by Mentha Capital
Business Support Services | Healthcare | Private Equity

BlijWerkt has been acquired by Mentha Capital

Gilde Healthcare Partners has sold BlijWerkt Groep B.V. to Mentha Capital.

Learn more
Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital
Private Equity | Healthcare

Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital

Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.

Learn more
“It was particularly pleasing to see the level of support received for this financing, reinforcing confidence in SNG001, our wholly-owned drug and potential breakthrough treatment for COVID-19 patients. Oaklins’ team has always been supportive and built a good register of institutions in March which was broadened further in this funding. It was a very successful fundraising and the level of demand was such that we were comfortably able to increase the size of the funding. Having demonstrated the great promise of SNG001 in hospitalized COVID-19 patients earlier this year, we now have the resources to be able to rapidly progress this potential breakthrough treatment in such a critical area of unmet need.”

Richard Marsden

CEO, Synairgen plc

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=FI&includes=featured_images,tags&language=en-FI&limit=1&tags=healthcare

Quarterly Highlights | Q2 2021

M&A and finding the right source of funding can play a significant role in accelerating recovery. Discover how we have collaborated closely, helping entrepreneurs and companies get a grip on the current situation and reach their full potential.

Learn more

Talk to our local advisors

 Marcus  Blomqvist

Marcus Blomqvist

Partner

Helsinki, Finland
Oaklins Finland

Meet our global industry specialists

 Robert  Boersma

Robert Boersma

Partner

Amsterdam, Netherlands
Oaklins Netherlands
 Dino  Theodorou

Dino Theodorou

Director

Johannesburg, South Africa
Oaklins Grindrod
 Stuart  Goodman

Stuart Goodman

Director

London, United Kingdom
Oaklins Smith & Williamson
 Michael  Jewell

Michael Jewell

Partner

London, United Kingdom
Oaklins Cavendish
 Michael S. Goldman

Michael S. Goldman

Managing Director

New York, United States
Oaklins TM Capital